NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

US STOCKS-Futures lifted by robust China factory data

Published 12/01/2020, 08:28 PM
Updated 12/01/2020, 08:30 PM
© Reuters.
UAL
-
TSLA
-
MRNA
-
ZM
-
BNTX
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window.)
* Pfizer-BioNTech seek EU emergency approval for COVID-19
vaccine
* China's Nov factory activity growth hits decade high
* Futures: Dow and S&P rise 1.1%, Nasdaq up 0.9%

By Shriya Ramakrishnan and Medha Singh
Dec 1 (Reuters) - U.S. stock index futures rose about 1% on
Tuesday as better-than-expected manufacturing data from China
and hopes that major drugmakers will roll out vaccines before
the end of the year increased bets of a quick recovery from the
COVID-19 crisis.
Investors are closely following updates on the handful of
leading vaccines as well as the start of global shipments as
drugmakers submit paperwork for regulatory approvals.
Drugmaker Pfizer Inc PFE.N gained about 3% in premarket
trade as the drugmaker and Germany's BioNTech SE BNTX.O sought
emergency approval of their vaccine from the European regulator.
The partners are now neck-and-neck with rival Moderna
MRNA.O , which said on Monday it would ask the EU regulator to
recommend conditional approval for its shot.
Cruise operators Carnival Corp CCL.N , Royal Caribbean
Cruises Ltd RCL.N and carriers Delta Air Lines Inc DAL.N and
United Airlines Holdings UAL.O rose between 2% and 5%.
Big U.S. banks, which are sensitive to the economic outlook,
gained between 1.4% and 2.1%.
Wall Street's main indexes ended lower on Monday on profit
taking at the end of the Dow's best month in more than three
decades as breakthroughs in vaccine development spurred a shift
towards sectors hardest-hit by virus induced shutdowns.
At 06:56 a.m. ET, Dow E-minis 1YMcv1 were up 1.13%, S&P
500 E-minis EScv1 were up 1.08% and Nasdaq 100 E-minis NQcv1
were up 0.92%.
China's factory sector activity grew at its fastest pace in
a decade in November, a business survey showed. Several other
countries also reported sharp upticks in industrial activity.
Later in the day, markets will focus on U.S. manufacturing
data for November as well as remarks from Treasury Secretary
Steven Mnuchin and Federal Reserve Chair Jerome Powell at a
congressional hearing.
Powell on Monday said that while the news on the vaccine
front is very positive, its impact on the economy will be
unclear until challenges such as vaccine production and mass
distribution are resolved. Among other stocks, Zoom Video Communications Inc ZM.O
dropped about 8% after the company warned its gross margins
would remain under pressure going into 2021. Tesla Inc TSLA.O rose about 5% after S&P Dow Jones Indices
said it would add one of Wall Street's most valuable companies
to the S&P 500 index all at once on Dec. 21.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.